Category Archives: "CMSC Consensus Statements"

2021 MAGNIMS-CMSC-NAIMS MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-up of MS
Clinician's User Manual Summary of 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple [...]
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
Prof Mike P Wattjes, MD, Prof Olga Ciccarelli, MD, Daniel S Reich, MD, Prof Brenda Banwell, MD, Prof Nicola de Stefano, MD, Prof Christian [...]
CMSC Consensus Statement on Neurofilament Biomarkers in Multiple Sclerosis
This consensus document was developed by an international panel of experts on neurofilament biomarker research and clinical applications in [...]
2019 CMSC Practical Guidelines for the Selection of Disease-Modifying Therapies in Multiple Sclerosis
This guideline was developed by a group of multiple sclerosis (MS) specialists, convened by the Consortium of Multiple Sclerosis Centers [...]
Comprehensive Palliative Care in MS: CMSC Consensus Statement and Proposed Guidelines
Several organizations have expressed interest and published guidelines or consensus statements emphasizing the need for palliative care for [...]
2018 CMSC MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-up of MS
MRI is widely used for the early and accurate diagnosis of multiple sclerosis (MS) and is used increasingly in patient follow-up. [...]
2017 Proposed MRI Revised Guidelines for Diagnosis and Follow-up of MS (UPDATED)
MRI is widely used for the early and accurate diagnosis of multiple sclerosis (MS) and is used increasingly in patient follow-up. [...]
2017 Proposed MRI Revised Guidelines for Diagnosis and Follow-up of MS
MRI is widely used for the early and accurate diagnosis of multiple sclerosis (MS) and is used increasingly in patient follow-up. [...]
ENS 2002 Guidelines for a standardized MRI protocol for MS
2001 CMSC Consensus Meeting, Vancouver MRI Protocol for the Diagnosis and Follow-up of [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last